> But with the Omicron variant now the dominant COVID strain in New York, both the city and state are facing severe shortages in the availability of effective antiviral monoclonal treatments
With the Omicron variant now the dominant strain, the evidence is that there are no effective antiviral monoclonal treatments; there are two that seem to be exceptions, but neither one is available or even in trials in the US.
